IDEXX Laboratories IDXX
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
Key Insights
IDEXX Laboratories (IDXX) Core Market Data and Business Metrics
Latest Closing Price
$426.25Price-Earnings Ratio
39.95Total Outstanding Shares
81.04 Million SharesDividend
No dividendSIC Description
In Vitro & In Vivo Diagnostic SubstancesPrimary Exchange
NASDAQHeadquarters
One Idexx Drive, Westbrook, ME, 04092-2041
Historical Stock Splits
If you bought 1 share of IDXX before November 27, 2007, you'd have 4 shares today.
| Execution Date | Split Amount |
|---|---|
| June 16, 2015 | 2-for-1 |
| November 27, 2007 | 2-for-1 |
Short Interest
Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
| Avg Daily Volume | Days to Cover | Settlement Date | Short Interest |
|---|---|---|---|
| 795,159 Shares | 3.8 | 3/14/2025 | 3,022,110 Shares |
| 727,116 Shares | 3.77 | 2/28/2025 | 2,737,631 Shares |
| 741,560 Shares | 2.85 | 2/14/2025 | 2,109,777 Shares |
| 807,191 Shares | 2.42 | 1/31/2025 | 1,956,517 Shares |
| 538,991 Shares | 3.21 | 1/15/2025 | 1,729,921 Shares |
| 502,515 Shares | 2.98 | 12/31/2024 | 1,495,773 Shares |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Financing Activities, Continuing | $-878.07 Million |
| Net Cash Flow, Continuing | $-156.13 Million |
| Net Cash Flow From Financing Activities | $-878.07 Million |
| Net Cash Flow From Investing Activities | $-207.06 Million |
| Net Cash Flow | $-165.67 Million |
| Exchange Gains/Losses | $-9.53 Million |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Provision For Loan, Lease, And Other Losses | $6.87 Million |
| Operating Expenses | $1.25 Billion |
| Income/Loss From Continuing Operations After Tax | $887.87 Million |
| Gross Profit | $2.38 Billion |
| Income/Loss From Continuing Operations Before Tax | $1.11 Billion |
| Basic Earnings Per Share | $10.77 |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss | $865.43 Million |
| Other Comprehensive Income/Loss | $-22.44 Million |
| Comprehensive Income/Loss Attributable To Parent | $865.43 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Noncurrent Assets | $1.89 Billion |
| Other Current Liabilities | $779.12 Million |
| Other Non-current Assets | $1.07 Billion |
| Equity Attributable To Parent | $1.60 Billion |
| Assets | $3.29 Billion |
| Accounts Payable | $114.21 Million |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||